Alzheimer’s disease affects millions of people worldwide; it’s often a disease that is undetectable until it’s too late. However, a new set of national guidelines are being released that will help catch signs of the disease earlier. David Shenk, author of “The Forgetting: Alzheimer’s, Portrait of an Epidemic,” explains the latest guidelines. The guidelines concern methods that assess brain changes including brain scans, tests of cerebral spinal fluid and other biomarkers. The ability to find markers means more research into the possibility of developing drugs to combat Alzheimer’s.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.